# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
TD Cowen analyst Joshua Jennings maintains Vericel (NASDAQ:VCEL) with a Buy and raises the price target from $55 to $60.
Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today a...
- SEC Filing
Approval Expands NexoBrid Target Customer Base to Include Approximately 20 Pediatric Burn CentersCAMBRIDGE, Mass., Aug. 15, 202...
Canaccord Genuity analyst Caitlin Cronin initiates coverage on Vericel (NASDAQ:VCEL) with a Buy rating and announces Price T...
Stephens & Co. analyst George Sellers maintains Vericel (NASDAQ:VCEL) with a Overweight and raises the price target from...